Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 81,876 | 77,816 | 112,155 | 80,106 | 73,755 |
| Marketable Securities | 36,265 | 38,605 | 68,702 | 92,731 | 98,563 |
| Receivables | 130,137 | 107,705 | 125,526 | 113,534 | 103,002 |
| Inventories | 144,401 | 148,652 | 140,161 | 102,698 | 114,959 |
| TOTAL | $400,695 | $380,128 | $454,006 | $396,813 | $397,566 |
| Non-Current Assets | |||||
| PPE Net | 21,778 | 20,458 | 20,967 | 20,022 | 21,644 |
| Investments And Advances | 71,909 | 77,956 | 87,514 | 103,426 | 105,639 |
| Intangibles | 469,656 | 474,895 | 363,074 | 370,089 | 364,464 |
| Other Non-Current Assets | 84,538 | 84,507 | 77,481 | 73,447 | 72,981 |
| TOTAL | $647,881 | $657,816 | $549,036 | $566,984 | $564,728 |
| Total Assets | $1,048,576 | $1,037,944 | $1,003,042 | $963,797 | $962,294 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 17,805 | 18,823 | 20,656 | 17,486 | 18,691 |
| Accounts payable and accrued liabilities | 112,852 | 104,936 | 117,748 | 78,345 | 86,620 |
| Other current liabilities | 9,705 | 18,408 | 2,551 | 1,876 | 2,193 |
| TOTAL | $152,676 | $153,946 | $152,612 | $111,248 | $118,152 |
| Non-Current Liabilities | |||||
| Long Term Debt | 78,740 | 78,842 | 26,333 | 25,899 | 32,960 |
| Other Non-Current Liabilities | 41,561 | 35,359 | 21,847 | 24,271 | 29,459 |
| TOTAL | $129,108 | $120,941 | $54,993 | $57,444 | $70,233 |
| Total Liabilities | $281,784 | $274,887 | $207,605 | $168,692 | $188,385 |
| Shareholders' Equity | |||||
| Common Shares | 532,792 | 532,642 | 531,160 | 534,266 | 539,317 |
| Retained earnings | 140,421 | 144,209 | 156,806 | 154,794 | 144,183 |
| Other shareholders' equity | 64,057 | 58,317 | 80,751 | 80,337 | 64,194 |
| TOTAL | $766,792 | $763,057 | $795,437 | $795,105 | $773,909 |
| Total Liabilities And Equity | $1,048,576 | $1,037,944 | $1,003,042 | $963,797 | $962,294 |